+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Blood Glucose Monitoring Devices Market 2020-2025 by Product, End-user, Geography and Impact of Covid-19 with Ansoff's Analysis

  • ID: 5178768
  • Report
  • October 2020
  • Region: Global
  • 130 pages
  • Infogence Marketing and Advisory Services
The Global Biostimulants Market is Estimated to Be USD 10.1 Bn in 2020 and is Expected to Reach USD 14.4 Bn by 2025 Growing at a CAGR of 7.3%

FEATURED COMPANIES

  • Abbott Laboratories
  • Adama
  • B. Braun Melsungen AG,
  • Biovert-Manvert
  • Eli Lilly and Company
  • FMC Corporation
  • MORE
Introduction
Diabetes has been considered as one of the chronic diseases affecting people of diverse age groups across the globe. Preventive care against diabetes and effective management can be done with the available Blood glucose monitoring devices in the market. Similarly, Blood glucose monitoring systems is a device used for monitoring the levels of blood sugar and the diagnosis of diabetes. These monitors vary in size, price, and its stated length of testing time.

The Global Biostimulants Market is estimated to be USD 10.1 Bn in 2020 and is expected to reach USD 14.4 Bn by 2025 growing at a CAGR of 7.3%.

Factors such as an increasing patient pool belonging to the diabetic category due to the increasing prevalence of diabetes have supported the growth of this market.

Conversely, the presence of alternative cheaper substitutes shall hinder the growth of this market.

Market Dynamics

Drivers
  • Rising geriatric population worldwide
  • Increasing number of patients with obesity and diabetes
  • Mere ease of use
Restraints
  • The high cost of devices
  • Presence of substitutes
Opportunities
  • Increasing awareness about the point of care testing (POCT)
  • Technological advancements in healthcare
Trends
  • Adoption to portable healthcare platforms
Segments Covered
The Global Blood Glucose Monitoring Devices market is further segmented based on product, end-user and geography.

Global Blood Glucose Monitoring Devices Market, By Product
  • Self-Monitoring Devices
  • Blood glucose meters market
  • Testing strips
  • Lancets
  • Continuous Blood Glucose Monitoring Devices
  • Sensors
  • Transmitter and receiver
  • Insulin pumps
Global Blood Glucose Monitoring Devices Market, By End User
  • Introduction
  • Hospitals
  • Homecare
  • Diagnostic Centers
Global Blood Glucose Monitoring Devices Market, By Geography
  • Introduction
  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa
Company Profiles
Some of the companies covered in this report are Abbott Laboratories, ARKRAY, Inc., Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, and Terumo Medical Corporation

Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share etc.
  • Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.
  • Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.
  • Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market
  • Tortoise: Companies which are slow in growth, having a long legacy and stable or negative in performance
Why buy this report?
  • The report offers a comprehensive evaluation of the Global Blood Glucose Monitoring Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
  • The report also contains a competitive analysis using Competitive Quadrant, the analyst's Proprietary competitive positioning tool.
Report Highlights:
  • A complete analysis of the market including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Adama
  • B. Braun Melsungen AG,
  • Biovert-Manvert
  • Eli Lilly and Company
  • FMC Corporation
  • MORE
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Trends

5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Blood Glucose Monitoring Devices Market, By Product
6.1 Self-Monitoring Devices
6.1.1 Blood glucose meters market
6.1.2 Testing strips
6.1.3 Lancets
6.2 Continuous Blood Glucose Monitoring Devices
6.2.1 Sensors
6.2.2 Transmitter and receiver
6.3 Insulin pumps

7 Global Blood Glucose Monitoring Devices Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Homecare
7.4 Diagnostic Centers

8 Global Blood Glucose Monitoring Devices Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Australia
8.5.5 Rest of APAC
8.6 Middle East and Africa

9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Competitive Scenario
9.3.1 Merger & Acquisition
9.3.2 Agreement, Collaboration, & Partnership
9.3.3 New Product Launch & Enhancement
9.3.4 Investment & Funding

10 Company Profiles
10.1 Abbott Laboratories
10.2 Medtronic plc
10.3 F. Hoffmann-La Roche Ltd
10.4 Bayer AG
10.5 Lifescan, Inc
10.6 B. Braun Melsungen AG,
10.7 Sanofi
10.8 Eli Lilly and Company
10.9 FMC Corporation
10.10 Adama
10.11 Koppert Biological Systems
10.12 Acadian Seaplants Limited
10.13 Biovert-Manvert
10.14 Haifa Group
10.15 SAPEC
10.16 Arkay, Inc
10.17 Dexcom, Inc.
10.18 Johnson & Johnson
10.19 Terumo Medical Corporation

11 Appendix
11.1 Questionnaire
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd
  • Bayer AG
  • Lifescan, Inc
  • B. Braun Melsungen AG,
  • Sanofi
  • Eli Lilly and Company
  • FMC Corporation
  • Adama
  • Koppert Biological Systems
  • Acadian Seaplants Limited
  • Biovert-Manvert
  • Haifa Group
  • SAPEC
  • Arkay, Inc
  • Dexcom, Inc.
  • Johnson & Johnson
  • Terumo Medical Corporation
Note: Product cover images may vary from those shown
Adroll
adroll